NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT
Post# of 155

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care, announced the pricing of its public offering of 5,882,353 shares at $1.70 per share, expecting to raise $10 million before deductions. The offering, underwritten by MDB Capital with Paulson Investment Company LLC participating as a selected dealer, is set to close on or about Feb. 14, 2025, subject to conditions. Proceeds will support commercial-readiness efforts, R&D, clinical and regulatory projects, and general corporate purposes. The underwriter has a 45-day option to purchase up to 882,353 additional shares to cover over-allotments.
NOTE TO INVESTORS: The latest news and updates relating to BEAT are available in the company’s newsroom at https://nnw.fm/BEAT
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer

